Literature DB >> 6897785

[Chemotherapy of gastric carcinoma].

S Seeber.   

Abstract

Improved chemotherapeutic results have been obtained recently with combinations of 5-fluorouracil, adriamycin, and mitomycin or a nitrosourea derivative. The response rates have been raised to 40%, and the median survival rate of responding patients has been increased to over 12 months. Regional disease should be treated by chemotherapy plus irradiation. Patients with curative resections are receiving adjuvant chemotherapy with improved regimens in various ongoing studies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6897785     DOI: 10.1007/bf01271761

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  5 in total

1.  Phase II-III chemotherapy studies in advanced gastric cancer. The Gastrointestinal Tumor Study Group.

Authors: 
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

2.  5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.

Authors:  J S MacDonald; P V Woolley; T Smythe; W Ueno; D Hoth; P S Schein
Journal:  Cancer       Date:  1979-07       Impact factor: 6.860

3.  Sequential and combination chemotherapy of advanced gastric cancer.

Authors:  C G Moertel; J A Mittelman; R F Bakemeier; P Engstrom; J Hanley
Journal:  Cancer       Date:  1976-08       Impact factor: 6.860

4.  Improved combination chemotherapy in advanced gastric cancer.

Authors:  J A Levi; D N Dalley; R S Aroney
Journal:  Br Med J       Date:  1979-12-08

5.  Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).

Authors:  J D Bitran; R K Desser; M F Kozloff; A A Billings; C M Shapiro
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.